ANTIDEPRESSANT TREATMENT PATTERNS, HEALTH CARE UTILIZATION AND COST AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)

被引：0
|
作者：
Isenberg, K. [1 ]
Eisenberg, D. [2 ]
Sanchez, R. [3 ]
Alvir, J. [3 ]
Wang, J. [4 ]
Gu, T. [2 ]
White, J. [4 ]
机构：
[1] Blue Cross Blue Shield Missouri, Kansas City, MO USA
[2] HealthCore Inc, Wilmington, DE USA
[3] Pfizer Inc, New York, NY USA
[4] WellPoint Inc, Thousand Oaks, CA USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.486
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A89 / A89
页数：1
相关论文
共 50 条
  • [21] Rumination in patients with major depressive disorder before and after antidepressant treatment
    Segerberg, Tina S. S.
    Ozenne, Brice
    Dam, Vibeke H.
    Kohler-Forsberg, Kristin
    Jorgensen, Martin B.
    Frokjaer, Vibe G.
    Knudsen, Gitte M.
    Stenbaek, Dea S.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2024, 360 : 322 - 325
  • [22] TREATMENT PERSISTENCE WITH DULOXETINE AND HEALTH CARE COSTS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Liu, X.
    Tepper, P.
    Mullins, C. D.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A112 - A113
  • [23] The effect of antidepressant treatment on quality of life in patients with major depressive disorder
    Aydemir, O.
    Ergun, H.
    Kesebir, S.
    Soygur, H.
    Tulunay, C. F.
    [J]. BIPOLAR DISORDERS, 2010, 12 : 5 - 5
  • [24] Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)
    Keyloun, Katelyn R.
    Hansen, Ryan N.
    Hepp, Zsolt
    Gillard, Patrick
    Thase, Michael E.
    Devine, Emily Beth
    [J]. CNS DRUGS, 2017, 31 (05) : 421 - 432
  • [25] WORKING MEMORY IMPAIRMENTS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
    Nazarboland, N.
    [J]. EUROPEAN PSYCHIATRY, 2010, 25
  • [26] Antidepressant adherence among outpatients with major depressive disorder
    Yassen, Ali Omar
    Mahmud, Nasraw Mustafa
    Bilal, Aya Diyar
    Wahab, Mohd Shahezwan Abd
    [J]. PHARMACIA, 2024, 71
  • [27] Medication Adherence, Health Care Utilization, and Costs in Patients With Major Depressive Disorder Initiating Adjunctive Atypical Antipsychotic Treatment
    Broder, Michael S.
    Greene, Mallik
    Yan, Tingjian
    Chang, Eunice
    Hartry, Ann
    Yermilov, Irina
    [J]. CLINICAL THERAPEUTICS, 2019, 41 (02) : 221 - 232
  • [28] Guideline-concordant antidepressant use among patients with major depressive disorder
    Chen, Shih-Yin
    Hansen, Richard A.
    Gaynes, Bradley N.
    Farley, Joel F.
    Morrissey, Joseph P.
    Maciejewski, Matthew L.
    [J]. GENERAL HOSPITAL PSYCHIATRY, 2010, 32 (04) : 360 - 367
  • [29] Efficacy of Antidepressant Medication in the Treatment of Major Depressive Disorder
    Anderson, Benjamin
    Muller, Andrew
    [J]. ARCHIVES OF CLINICAL PSYCHIATRY, 2023, 50 (01) : 123 - 129
  • [30] Vortioxetine: a novel antidepressant for the treatment of major depressive disorder
    Gonda, Xenia
    Sharma, Samata R.
    Tarazi, Frank I.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2019, 14 (01) : 81 - 89
12345